Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 101: What is true about the half-life (t 1/2) of a drug?

A. The time required for the plasma concentration of a drug to be reduced by half. (Correct Answer)
B. In zero-order kinetics, the half-life remains constant.
C. In first-order kinetics, the half-life increases.
D. Complete drug elimination occurs in 2-3 half-lives.

Explanation: ### Explanation **1. Why Option A is Correct:** The **half-life ($t_{1/2}$)** is defined as the time required for the plasma concentration of a drug to decrease by 50%. It is a critical pharmacokinetic parameter that determines the dosing interval and the time required to reach a steady state. Mathematically, for first-order kinetics, it is expressed as: $$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ *(where $V_d$ is Volume of Distribution and $CL$ is Clearance)*. **2. Why the Other Options are Incorrect:** * **Option B:** In **Zero-order kinetics**, a constant *amount* of drug is eliminated per unit time, not a constant fraction. Therefore, the half-life is **not constant**; it decreases as the plasma concentration decreases. * **Option C:** In **First-order kinetics** (followed by most drugs), a constant *fraction* of the drug is eliminated per unit time. Here, the half-life remains **constant** regardless of the plasma concentration or dose administered. * **Option D:** It takes approximately **4 to 5 half-lives** to reach a steady state and similarly **4 to 5 half-lives** for a drug to be considered "completely" eliminated from the body (at 4 $t_{1/2}$, ~93.75% is cleared; at 5 $t_{1/2}$, ~96.8% is cleared). **3. High-Yield Clinical Pearls for NEET-PG:** * **Steady State:** Reached after 4–5 half-lives. It is the point where the rate of drug administration equals the rate of elimination. * **Loading Dose:** Used to achieve therapeutic concentrations rapidly (reaches steady state immediately). It depends primarily on the **Volume of Distribution ($V_d$)**. * **Maintenance Dose:** Used to maintain the steady state. It depends primarily on **Clearance ($CL$)**. * **Zero-order examples (High-yield mnemonic: "WATT"):** **W**arfarin (at high doses), **A**lcohol (Ethanol), **T**heophylline, **T**olbutamide, **P**henytoin, and **A**spirin (at high doses).

Question 102: Which of the following is an example of a Phase I xenobiotic reaction?

A. Acetylation
B. Hydroxylation (Correct Answer)
C. Methylation
D. Glucuronidation

Explanation: Drug metabolism (biotransformation) occurs in two distinct phases to convert lipophilic drugs into hydrophilic metabolites for excretion [1, 2]. **Phase I Reactions (Nonsynthetic)** These reactions involve the introduction or unmasking of a functional group (like –OH, –NH2, or –SH). The primary goal is to make the molecule more polar or prepare it for Phase II [2]. * **Hydroxylation** is a classic example of an **Oxidation** reaction, which is the most common Phase I process, typically mediated by the Cytochrome P450 (CYP450) enzyme system [2]. Other Phase I reactions include reduction and hydrolysis [1, 2]. **Explanation of Incorrect Options** Options A, C, and D are all **Phase II Reactions (Synthetic)**. These involve the **conjugation** of a drug or its Phase I metabolite with an endogenous substance to form a highly polar, inactive conjugate [2]. * **Acetylation (A):** Catalyzed by NAT enzymes (e.g., Isoniazid, Hydralazine) [1]. * **Methylation (C):** Transfer of a methyl group (e.g., Epinephrine, Dopamine). * **Glucuronidation (D):** The most common Phase II reaction, catalyzed by UGT enzymes (e.g., Morphine, Bilirubin) [2]. **High-Yield NEET-PG Pearls:** * **Mnemonic for Phase II:** "S-M-A-G" (Sulfation, Methylation, Acetylation, Glucuronidation). * **Exception:** Most Phase II metabolites are inactive [1], but **Morphine-6-glucuronide** is more potent than morphine itself. * **Microsomal vs. Non-microsomal:** Glucuronidation is the only Phase II reaction that occurs in the microsomes; all others are non-microsomal (cytosolic). * **Age Factor:** Neonates are deficient in glucuronidation, leading to **Gray Baby Syndrome** with Chloramphenicol.

Question 103: Which drug follows first-order kinetics for elimination?

A. Opioids
B. Verapamil
C. Lignocaine
D. All of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. All of the above.** **Underlying Concept: First-Order vs. Zero-Order Kinetics** Most drugs follow **First-Order Kinetics**, where a constant *fraction* of the drug is eliminated per unit of time. The rate of elimination is directly proportional to the plasma concentration. In contrast, **Zero-Order Kinetics** occurs when a constant *amount* of drug is eliminated per unit of time because the elimination pathways (enzymes/transporters) are saturated. **Analysis of Options:** * **Opioids (e.g., Morphine):** These are metabolized primarily by the liver via glucuronidation. At therapeutic doses, the enzymes are not saturated, following first-order kinetics. * **Verapamil:** A calcium channel blocker that undergoes extensive first-pass metabolism. It follows first-order kinetics, meaning its half-life remains constant regardless of the dose. * **Lignocaine:** An amide local anesthetic and antiarrhythmic. It is cleared by the liver with a high extraction ratio, following first-order kinetics under normal physiological conditions. **High-Yield Clinical Pearls for NEET-PG:** To excel in NEET-PG, it is more efficient to memorize the exceptions—drugs that follow **Zero-Order Kinetics** (Non-linear kinetics)—using the mnemonic **"WATT P"**: * **W**arfarin * **A**lcohol (Ethanol) * **T**heophylline * **T**olbutamide * **P**henytoin / **P**ropanol (at high doses) / **P**yrazinamide / **P**alicylates (Aspirin) **Key Distinction:** For first-order drugs, the **Half-life ($t_{1/2}$)** is constant. For zero-order drugs, the half-life varies with the dose, increasing as the plasma concentration increases.

Question 104: Which of the following is a phase-2 reaction?

A. Oxidation
B. Reduction
C. Cyclination
D. Acetylation (Correct Answer)

Explanation: **Explanation:** Drug metabolism (biotransformation) typically occurs in two phases to make lipid-soluble drugs more water-soluble for excretion. **1. Why Acetylation is Correct:** **Acetylation** is a **Phase-II (Conjugative) reaction**. Phase-II reactions involve the attachment of an endogenous group (like acetate, glucuronate, or sulfate) to a drug or its metabolite. These reactions generally result in polar, inactive, and easily excretable compounds. Other Phase-II reactions include Glucuronidation (most common), Sulfation, Methylation, and Glutathione conjugation. **2. Analysis of Incorrect Options:** * **Oxidation (A) and Reduction (B):** These are **Phase-I (Non-synthetic) reactions**. Phase-I reactions introduce or expose a functional group (–OH, –NH2, –SH) through oxidation, reduction, or hydrolysis. Oxidation is the most common Phase-I reaction, primarily mediated by the Cytochrome P450 system. * **Cyclination (C):** This is also a **Phase-I reaction** where a straight-chain compound is converted into a ring structure (e.g., proguanil to cycloguanil). **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Phase-II:** "**S**ticky **G**roups **M**ake **A**ll **G**one" (**S**ulfation, **G**lucuronidation, **M**ethylation, **A**cetylation, **G**lutathione conjugation). * **Acetylation Polymorphism:** This is clinically significant for drugs like **Isoniazid (INH), Hydralazine, Procainamide, and Dapsone**. "Slow acetylators" are at a higher risk of toxicity (e.g., peripheral neuropathy with INH or SLE-like syndrome with Hydralazine). * **Exception to the Rule:** While Phase-II usually inactivates drugs, **Morphine-6-glucuronide** is a Phase-II metabolite that is *more* active than morphine itself.

Question 105: A patient infected with MRSA requires dialysis and has been started on linezolid. On the day of dialysis, when should linezolid be administered in this patient?

A. After dialysis (Correct Answer)
B. Before dialysis
C. Can be administered irrespective of dialysis
D. During dialysis

Explanation: Explanation: The correct answer is **After dialysis (Option A)**. **Why it is correct:** Linezolid is an oxazolidinone antibiotic used for MRSA and VRE infections [1]. While it is primarily metabolized by the liver, approximately **30% of the drug is cleared by hemodialysis**. If administered before or during the procedure, a significant portion of the therapeutic dose would be "washed out" of the blood, leading to sub-therapeutic plasma concentrations and potential treatment failure or the development of resistance. Therefore, to ensure maximum efficacy and maintain steady-state levels, the dose must be administered **after** the dialysis session is completed. **Why other options are incorrect:** * **Before dialysis (Option B):** Administering the drug before the session results in rapid clearance by the dialyzer, reducing the drug's half-life and efficacy. * **Irrespective of dialysis (Option C):** This is incorrect because linezolid is dialyzable. Only drugs that are not cleared by dialysis (e.g., Ceftriaxone) can be given without regard to the timing of the procedure. * **During dialysis (Option D):** The drug would be filtered out almost as quickly as it is infused, wasting the dose. **High-Yield Clinical Pearls for NEET-PG:** * **Linezolid Spectrum:** Covers Gram-positive organisms including MRSA, VRSA, and VRE [1]. * **Mechanism:** Inhibits protein synthesis by binding to the **23S ribosomal RNA of the 50S subunit**, preventing the formation of the 70S initiation complex. * **Side Effects:** Prolonged use (>2 weeks) can cause **thrombocytopenia** (monitor CBC) and **optic/peripheral neuropathy**. * **Drug Interaction:** It is a weak MAO inhibitor; avoid tyramine-rich foods and SSRIs to prevent **Serotonin Syndrome**.

Question 106: Steady-state plasma concentration obtained after a dosage regimen depends on which of the following?

A. Duration of action of the drug
B. Dosing rate (Correct Answer)
C. Half-life of a drug
D. Dosage interval

Explanation: **Explanation:** The **Steady-State Concentration ($C_{ss}$)** is the point during a drug dosage regimen where the rate of drug administration (input) equals the rate of drug elimination (output) [1]. **1. Why "Dosing Rate" is Correct:** The fundamental formula for steady-state concentration is: $C_{ss} = \frac{\text{Dosing Rate}}{\text{Clearance (CL)}}$ [1] The **Dosing Rate** is the amount of drug administered per unit of time (e.g., mg/hr). Since $C_{ss}$ is directly proportional to the dosing rate, any change in the rate of administration will directly alter the plateau concentration [3]. If you double the dosing rate, you double the $C_{ss}$. **2. Why the Other Options are Incorrect:** * **Duration of Action (A):** This is a clinical effect of the drug's pharmacodynamics and half-life, not a determinant of the plasma level achieved at steady state. * **Half-life ($t_{1/2}$) (C):** This is a common distractor. Half-life determines the **time taken** to reach steady state (usually 4–5 half-lives), but it does not determine the **level (concentration)** of the steady state itself [3]. * **Dosage Interval (D):** While the interval affects the "fluctuations" (peaks and troughs) between doses, the average $C_{ss}$ is determined by the total dosing rate (Dose/Interval) [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Time to Steady State:** It takes approximately **4 to 5 half-lives** to reach steady state, regardless of the dose or dosing interval [3]. * **Loading Dose:** Used to achieve therapeutic levels rapidly (bypassing the 4–5 half-lives wait), but it does not change the final $C_{ss}$ [2]. * **Maintenance Dose:** Calculated based on Clearance to maintain the $C_{ss}$ [1]. * **Key Formula:** $\text{Dosing Rate} = C_{ss} \times \text{Clearance}$.

Question 107: What is the most important factor governing the absorption of a drug from intact skin?

A. Molecular weight of the drug
B. Site of application
C. Lipid solubility of the drug (Correct Answer)
D. Nature of the base used in the formulation

Explanation: The absorption of drugs through intact skin (transdermal absorption) occurs primarily via passive diffusion through the stratum corneum, the outermost layer of the epidermis [1]. This layer acts as a lipid-rich, semi-permeable barrier. 1. Why Lipid Solubility is Correct: The stratum corneum is composed of keratinized cells embedded in a lipid matrix. For a drug to penetrate this barrier, it must be highly lipid-soluble. According to Fick’s Law of Diffusion, the rate of movement across a biological membrane is directly proportional to the lipid-water partition coefficient [1]. Therefore, lipid solubility is the primary determinant of how effectively a drug can cross the skin into the systemic circulation. 2. Analysis of Incorrect Options: * Molecular Weight (A): While smaller molecules cross more easily, lipid solubility is the more critical prerequisite. Even small molecules cannot cross if they are highly hydrophilic. * Site of Application (B): Skin thickness varies (e.g., thin on the scrotum/post-auricular area, thick on palms/soles), which affects the rate of absorption, but it is not the fundamental property of the drug governing the process. * Nature of the Base (D): The vehicle (ointment vs. cream) can enhance absorption by hydrating the stratum corneum or increasing drug contact time, but it remains secondary to the drug’s intrinsic lipid solubility. Clinical Pearls for NEET-PG: * Hydration: Absorption is significantly increased if the skin is well-hydrated (e.g., using occlusive dressings). * Organophosphates: These are highly lipid-soluble, explaining why systemic toxicity occurs rapidly after accidental skin contact. * Pro-drug approach: Highly polar drugs are often converted into lipid-soluble esters to improve topical penetration.

Question 108: What is the primary route of administration for GnRH analogues?

A. Subcutaneous (Correct Answer)
B. Oral
C. Intravenous
D. Transdermal

Explanation: **Explanation:** **1. Why Subcutaneous is Correct:** GnRH (Gonadotropin-Releasing Hormone) analogues, such as **Leuprolide, Goserelin, and Nafarelin**, are synthetic decapeptides. Because they are peptides, they are susceptible to rapid degradation by proteolytic enzymes in the gastrointestinal tract if taken orally. The **subcutaneous (SC)** route is preferred because it allows for the formulation of **depot preparations**. These depots provide a sustained, slow release of the drug over weeks or months, which is essential for achieving the therapeutic goal of "medical castration" (downregulation of GnRH receptors to suppress FSH and LH). **2. Why Other Options are Incorrect:** * **Oral:** As mentioned, GnRH analogues are peptides. They have poor bioavailability due to gastric acid degradation and first-pass metabolism. * **Intravenous (IV):** While possible, the IV route results in a very short half-life (minutes) and lacks the sustained-release profile required for chronic conditions like prostate cancer or endometriosis. * **Transdermal:** The large molecular size and hydrophilic nature of these peptides make them unsuitable for passive diffusion through the skin barrier. **3. Clinical Pearls for NEET-PG:** * **Biphasic Action:** Initial administration causes a "flare-up" (transient increase in LH/FSH), followed by downregulation and desensitization of pituitary GnRH receptors. * **Alternative Route:** **Intranasal** administration (e.g., Nafarelin) is used for shorter-term indications like endometriosis or precocious puberty, though SC remains the primary route for long-term therapy. * **Therapeutic Uses:** Prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. * **Antagonists vs. Agonists:** Unlike analogues (agonists), GnRH **antagonists** (e.g., Degarelix, Cetrorelix) produce immediate suppression without the initial flare-up.

Question 109: Which of the following is a prodrug?

A. Neostigmine
B. Captopril
C. Esmolol
D. Enalapril (Correct Answer)

Explanation: **Explanation:** **1. Why Enalapril is the Correct Answer:** A **prodrug** is a pharmacologically inactive compound that must be metabolized within the body (usually by the liver or plasma esterases) to become an active metabolite. **Enalapril** is an ester prodrug that undergoes hepatic hydrolysis by esterases to form **Enalaprilat**, which is the active ACE inhibitor. This conversion is necessary because Enalaprilat itself has poor oral bioavailability due to its highly polar nature. **2. Why the Other Options are Incorrect:** * **Neostigmine:** This is an active quaternary ammonium compound used in Myasthenia Gravis. Unlike its relative *Physostigmine*, it is polar and does not cross the blood-brain barrier, but it acts directly without metabolic activation. * **Captopril:** Unlike most ACE inhibitors (which are prodrugs), Captopril is **active as such**. It does not require hepatic activation, making it useful in patients with liver dysfunction. * **Esmolol:** This is an ultra-short-acting beta-blocker that is **active upon administration**. It is unique because it is rapidly inactivated (not activated) by red blood cell esterases. **3. High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Rule:** All ACE inhibitors are prodrugs **EXCEPT Captopril and Lisinopril**. * **Active Metabolites:** Remember that **Enalaprilat** is the only ACE inhibitor available for intravenous use because it bypasses the need for hepatic activation. * **Other common prodrugs to remember:** Levodopa (to Dopamine), Prednisone (to Prednisolone), Cyclophosphamide (to Phosphoramide mustard), and Clopidogrel. * **Advantage of Prodrugs:** They are often designed to improve oral absorption, decrease toxicity, or prolong the duration of action.

Question 110: Which of the following drugs undergoes most of its metabolism presystemically?

A. Salbutamol
B. Verapamil
C. Propranolol (Correct Answer)
D. Paracetamol

Explanation: ### Explanation **Correct Answer: C. Propranolol** **Concept: First-Pass (Presystemic) Metabolism** First-pass metabolism refers to the extensive degradation of a drug in the liver or gut wall before it reaches the systemic circulation. Drugs with high first-pass metabolism have low **oral bioavailability**, necessitating much higher oral doses compared to intravenous doses. **Why Propranolol is correct:** Propranolol is the classic example of a drug with a very high first-pass effect (extraction ratio > 0.7). Approximately **75%** of an oral dose is metabolized by the liver during its first passage through the portal circulation. Consequently, the oral dose of Propranolol (e.g., 40–80 mg) is significantly higher than the IV dose (e.g., 1–3 mg) to achieve the same therapeutic effect. **Analysis of Incorrect Options:** * **A. Salbutamol:** While it undergoes some metabolism in the gut wall (sulfation), its presystemic extraction is not as extensive as Propranolol's. It maintains sufficient bioavailability for oral administration. * **B. Verapamil:** Verapamil does undergo significant first-pass metabolism (bioavailability ~20%), but in the context of standard pharmacological teaching and competitive exams, **Propranolol** is considered the prototypical example of high hepatic extraction. * **D. Paracetamol:** It has excellent oral bioavailability (~88–90%) with negligible first-pass metabolism, making it highly effective when taken orally. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for High First-Pass Metabolism:** "**L**ive **L**ife **T**hru **P**roper **M**edication" (**L**ignocaine, **L**abetalol, **T**ricyclic antidepressants, **P**ropranolol/Pethidine, **M**orphine). * **Nitroglycerin:** Has nearly 100% first-pass metabolism, which is why it is administered **sublingually** to bypass the liver. * **Bioavailability (F):** Calculated as (AUC oral / AUC IV) × 100. Drugs with high first-pass metabolism have a low "F" value.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free